Sartore-Bianchi A - Search Results

1

PIK3CA mutations in colorectal cancer are associated with clinical resistance to EGFR-targeted monoclonal antibodies.

Sartore-Bianchi A, Martini M, Molinari F, Veronese S, Nichelatti M, Artale S, Di Nicolantonio F, Saletti P, De Dosso S, Mazzucchelli L, Frattini M, Siena S, Bardelli A. Sartore-Bianchi A, et al. Cancer Res. 2009 Mar 1;69(5):1851-7. doi: 10.1158/0008-5472.CAN-08-2466. Epub 2009 Feb 17. Cancer Res. 2009. PMID: 19223544

2

Controversies in the management of brain metastases: the role of chemotherapy.

Landonio G, Sartore-Bianchi A, Giannetta L, Renga M, Riva M, Siena S. Landonio G, et al. Forum (Genova). 2001 Jan-Mar;11(1):59-74. Forum (Genova). 2001. PMID: 11734865 Review.

3

Gene copy number for epidermal growth factor receptor (EGFR) and clinical response to antiEGFR treatment in colorectal cancer: a cohort study.

Moroni M, Veronese S, Benvenuti S, Marrapese G, Sartore-Bianchi A, Di Nicolantonio F, Gambacorta M, Siena S, Bardelli A. Moroni M, et al. Lancet Oncol. 2005 May;6(5):279-86. doi: 10.1016/S1470-2045(05)70102-9. Lancet Oncol. 2005. PMID: 15863375 Clinical Trial.

4

Somatic mutation of EGFR catalytic domain and treatment with gefitinib in colorectal cancer.

Moroni M, Sartore-Bianchi A, Benvenuti S, Artale S, Bardelli A, Siena S. Moroni M, et al. Ann Oncol. 2005 Nov;16(11):1848-9. doi: 10.1093/annonc/mdi356. Epub 2005 Jul 12. Ann Oncol. 2005. PMID: 16012179 Free article. No abstract available.

5

Anti-EGFR monoclonal antibodies in the treatment of non-small cell lung cancer.

Sartore-Bianchi A, Cerea G, Schiavetto I, Giannetta L, Ricotta R, Maugeri MR, Moroni M, Marrapese G, Siena S. Sartore-Bianchi A, et al. Ann Oncol. 2006 Mar;17 Suppl 2:ii49-51. doi: 10.1093/annonc/mdj922. Ann Oncol. 2006. PMID: 16608982 Free article. Review. No abstract available.

6

Cetuximab for treatment of metastatic colorectal cancer.

Cerea G, Ricotta R, Schiavetto I, Maugeri MR, Sartore-Bianchi A, Moroni M, Artale S, Siena S. Cerea G, et al. Ann Oncol. 2006 Jun;17 Suppl 7:vii66-7. doi: 10.1093/annonc/mdl954. Ann Oncol. 2006. PMID: 16760297 Free article.

7

Oncogenic activation of the RAS/RAF signaling pathway impairs the response of metastatic colorectal cancers to anti-epidermal growth factor receptor antibody therapies.

Benvenuti S, Sartore-Bianchi A, Di Nicolantonio F, Zanon C, Moroni M, Veronese S, Siena S, Bardelli A. Benvenuti S, et al. Cancer Res. 2007 Mar 15;67(6):2643-8. doi: 10.1158/0008-5472.CAN-06-4158. Cancer Res. 2007. PMID: 17363584

8

Rationale and clinical results of multi-target treatments in oncology.

Sartore-Bianchi A, Ricotta R, Cerea G, Maugeri MR, Siena S. Sartore-Bianchi A, et al. Int J Biol Markers. 2007 Jan-Mar;22(1 Suppl 4):S77-87. Int J Biol Markers. 2007. PMID: 17520585 Review.

9

Epidermal growth factor receptor gene copy number and clinical outcome of metastatic colorectal cancer treated with panitumumab.

Sartore-Bianchi A, Moroni M, Veronese S, Carnaghi C, Bajetta E, Luppi G, Sobrero A, Barone C, Cascinu S, Colucci G, Cortesi E, Nichelatti M, Gambacorta M, Siena S. Sartore-Bianchi A, et al. J Clin Oncol. 2007 Aug 1;25(22):3238-45. doi: 10.1200/JCO.2007.11.5956. J Clin Oncol. 2007. PMID: 17664472 Clinical Trial.

10

EGFR FISH in colorectal cancer: what is the current reality?

Moroni M, Sartore-Bianchi A, Veronese S, Siena S. Moroni M, et al. Lancet Oncol. 2008 May;9(5):402-3. doi: 10.1016/S1470-2045(08)70109-8. Lancet Oncol. 2008. PMID: 18452847 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

191 results

Search Page

Filters